Researchers at the Universitat Oberta de Catalunya and the Institute of Photonic Sciences have created a Raman spectral ...
News-Medical.Net on MSN
Innovative research reveals FGD3 as a key player in breast cancer cell death
A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...
2hon MSN
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
Get the latest on Vistagen Therapeutics' Q2 2026 earnings, PALISADE-3 trial milestones, and upcoming fasedienol data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback